Catalyst Pharmaceuticals Inc. appointed Daniel Brennan as chief commercial officer.
Brennan will lead the biopharmaceutical company's marketing, sales and commercial operations. He most recently served as COO at Edge Therapeutics Inc.
Catalyst Pharmaceuticals names chief commercial officer
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
Catalyst Pharmaceuticals names chief commercial officer
- Author Faizan Farooque
- Theme Healthcare & Pharmaceuticals
- Author
- Faizan Farooque
- Theme
- Healthcare & Pharmaceuticals